212 related articles for article (PubMed ID: 7544320)
1. Mutation analysis of ten exons of the CFTR gene in Greek cystic fibrosis patients: characterization of 74.5% of CF alleles including one novel mutation.
Kanavakis E; Tzetis M; Antoniadi T; Traeger-Synodinos J; Doudounakis S; Adam G; Matsaniotis N; Kattamis C
Hum Genet; 1995 Sep; 96(3):364-6. PubMed ID: 7544320
[TBL] [Abstract][Full Text] [Related]
2. Mutation analysis in 600 French cystic fibrosis patients.
Chevalier-Porst F; Bonardot AM; Gilly R; Chazalette JP; Mathieu M; Bozon D
J Med Genet; 1994 Jul; 31(7):541-4. PubMed ID: 7525963
[TBL] [Abstract][Full Text] [Related]
3. The occurrence of various non-delta F508 CFTR gene mutations among Hungarian cystic fibrosis patients.
Nemeti M; Johnson JP; Papp Z; Louie E
Hum Genet; 1992 May; 89(2):245-6. PubMed ID: 1375186
[TBL] [Abstract][Full Text] [Related]
4. Mutation analysis of CFTR gene in 70 Iranian cystic fibrosis patients.
Alibakhshi R; Zamani M
Iran J Allergy Asthma Immunol; 2006 Mar; 5(1):3-8. PubMed ID: 17242497
[TBL] [Abstract][Full Text] [Related]
5. Study of 12 mutations in Turkish cystic fibrosis patients.
Yilmaz E; Erdem H; Ozgüç M; Coşkun T; Ozçelik U; Göçmen A; Ozalp I
Hum Hered; 1995; 45(3):175-7. PubMed ID: 7542223
[TBL] [Abstract][Full Text] [Related]
6. Molecular and clinical findings in Austrian cystic fibrosis patients with mutations in exon 11 of the CFTR gene.
Greil I; Wagner K; Eber E; Zach M; Rosenkranz W
Wien Klin Wochenschr; 1995; 107(15):464-9. PubMed ID: 7545856
[TBL] [Abstract][Full Text] [Related]
7. Screening for non-delta F508 mutations in five exons of the cystic fibrosis transmembrane conductance regulator (CFTR) gene in Italy.
Devoto M; Ronchetto P; Fanen P; Orriols JJ; Romeo G; Goossens M; Ferrari M; Magnani C; Seia M; Cremonesi L
Am J Hum Genet; 1991 Jun; 48(6):1127-32. PubMed ID: 1709778
[TBL] [Abstract][Full Text] [Related]
8. Characterization of more than 85% of cystic fibrosis alleles in the Greek population, including five novel mutations.
Tzetis M; Kanavakis E; Antoniadi T; Doudounakis S; Adam G; Kattamis C
Hum Genet; 1997 Jan; 99(1):121-5. PubMed ID: 9003508
[TBL] [Abstract][Full Text] [Related]
9. Spectrum of CFTR mutations in Argentine cystic fibrosis patients.
Chertkoff L; Visich A; Bienvenu T; Grenoville M; Segal E; Carniglia L; Kaplan JC; Barreiro C
Clin Genet; 1997 Jan; 51(1):43-7. PubMed ID: 9084934
[TBL] [Abstract][Full Text] [Related]
10. Mutation characterization of CFTR gene in 206 Northern Irish CF families: thirty mutations, including two novel, account for approximately 94% of CF chromosomes.
Hughes DJ; Hill AJ; Macek M; Redmond AO; Nevin NC; Graham CA
Hum Mutat; 1996; 8(4):340-7. PubMed ID: 8956039
[TBL] [Abstract][Full Text] [Related]
11. Molecular characterization of cystic fibrosis: 16 novel mutations identified by analysis of the whole cystic fibrosis conductance transmembrane regulator (CFTR) coding regions and splice site junctions.
Fanen P; Ghanem N; Vidaud M; Besmond C; Martin J; Costes B; Plassa F; Goossens M
Genomics; 1992 Jul; 13(3):770-6. PubMed ID: 1379210
[TBL] [Abstract][Full Text] [Related]
12. Extended haplotype analysis of cystic fibrosis mutations and its implications for the selective advantage hypothesis.
Sereth H; Shoshani T; Bashan N; Kerem BS
Hum Genet; 1993 Oct; 92(3):289-95. PubMed ID: 7691712
[TBL] [Abstract][Full Text] [Related]
13. A rapid, efficient, and sensitive assay for simultaneous detection of multiple cystic fibrosis mutations.
Costes B; Fanen P; Goossens M; Ghanem N
Hum Mutat; 1993; 2(3):185-91. PubMed ID: 7689902
[TBL] [Abstract][Full Text] [Related]
14. Cystic fibrosis in Lebanon: distribution of CFTR mutations among Arab communities.
Desgeorges M; Mégarbané A; Guittard C; Carles S; Loiselet J; Demaille J; Claustres M
Hum Genet; 1997 Aug; 100(2):279-83. PubMed ID: 9254864
[TBL] [Abstract][Full Text] [Related]
15. Identification of the linkage of mutations causing cystic fibrosis to different alleles of a tetranucleotide repeat in intron 6a of the CFTR gene.
Potapova OYu ; Voronina OV; Gaitskhoki VS; Bogacheva EV; Uembitskaya TE; Kuprina EA; Kapranov NI; Berlin YuA ; Schwartz EI
Biochem Med Metab Biol; 1994 Apr; 51(2):185-7. PubMed ID: 7519028
[TBL] [Abstract][Full Text] [Related]
16. 394delTT: a Nordic cystic fibrosis mutation.
Schwartz M; Anvret M; Claustres M; Eiken HG; Eiklid K; Schaedel C; Stolpe L; Tranebjaerg L
Hum Genet; 1994 Feb; 93(2):157-61. PubMed ID: 7509310
[TBL] [Abstract][Full Text] [Related]
17. Screening for five mutations detects 97% of cystic fibrosis (CF) chromosomes and predicts a carrier frequency of 1:29 in the Jewish Ashkenazi population.
Abeliovich D; Lavon IP; Lerer I; Cohen T; Springer C; Avital A; Cutting GR
Am J Hum Genet; 1992 Nov; 51(5):951-6. PubMed ID: 1384328
[TBL] [Abstract][Full Text] [Related]
18. Exon 9 of the CFTR gene: splice site haplotypes and cystic fibrosis mutations.
Dörk T; Fislage R; Neumann T; Wulf B; Tümmler B
Hum Genet; 1994 Jan; 93(1):67-73. PubMed ID: 7505767
[TBL] [Abstract][Full Text] [Related]
19. Genetic determination of exocrine pancreatic function in cystic fibrosis.
Kristidis P; Bozon D; Corey M; Markiewicz D; Rommens J; Tsui LC; Durie P
Am J Hum Genet; 1992 Jun; 50(6):1178-84. PubMed ID: 1376016
[TBL] [Abstract][Full Text] [Related]
20. Cystic fibrosis in Greece: molecular diagnosis, haplotypes, prenatal diagnosis and carrier identification amongst high-risk individuals.
Kanavakis E; Efthymiadou A; Strofalis S; Doudounakis S; Traeger-Synodinos J; Tzetis M
Clin Genet; 2003 May; 63(5):400-9. PubMed ID: 12752573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]